Irinotecan/Panitumumab/Vemurafenib Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C153482
A chemoimmunotherapy regimen consisting of irinotecan, panitumumab and vemurafenib that can be used for the treatment of colon cancer. [ ]
Term info
Label
Irinotecan/Panitumumab/Vemurafenib Regimen
Synonyms
- Irinotecan + Panitumumab + Vemurafenib
- Irinotecan + Panitumumab + Vemurafenib Regimen
- Irinotecan + Panitumumab Regimen
- Irinotecan-Panitumumab-Vemurafenib
- Irinotecan-Panitumumab-Vemurafenib Regimen
- Irinotecan/Panitumumab/Vemurafenib
- Irinotecan/Panitumumab/Vemurafenib Regimen
Subsets
NCIT_C160952, NCIT_C160950
DesignNote
NCCN guidelines 2018
NCI META CUI
CL554977
Preferred Name
Irinotecan/Panitumumab/Vemurafenib Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C153482